Recent studies have extensively explored the potential of GDF-15 as an emerging disease prognosis biomarker in various human conditions such as type 2 diabetes, CVD and cancer clinical outcome and tumor progression (7, 34, 35). This evidence concerns the gene GDF15 and neoplasm.